Just as the owner of a once economical four-door sedan reaches for a credit card to pay nearly $4 a gallon at the gas pump, biotech executives do the same, only they're fueling a more costly research and development engine and their credit comes in the form of cautious investors. (BioWorld Financial Watch) Read More
